Skip to main content
. 2021 Oct 11;7(3):249–257. doi: 10.5114/ceh.2021.109312

Fig. 2.

Fig. 2

A current world map showing lenvatinib approval for unresectable hepatocellular carcinoma in each country worldwide, as described by Eisai Global. The country, month and year of approval are stated in the legend [29]